Exeliom Biosciences (private company)

See something wrong or missing? Let us know
Offices:Dijon
Business model:B2B

Exeliom Biosciences is a clinical-stage biopharmaceutical company from France specialized in the development of microbiome-based immunotherapies with a mission to bring innovation to the treatment of inflammatory bowel diseases, cancer, and infectious diseases

Investors: we tracked 5 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 23.75M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Exeliom Biosciences

Name Criteria
France AbolerIS Pharma
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Denmark Acesion Pharma
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Achilles Therapeutics
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Denmark Antag Therapeutics
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Sweden Aprea Therapeutics
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Spain Arthex Biotech S.L.
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Germany Atai Life Sciences
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
United Kingdom Biofidelity
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Sweden BoneSupport
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Germany CatalYm
53%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Top